Levoleucovorin (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Levoleucovorin drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Levoleucovorin
SUBSTANCE NAME: LEVOLEUCOVORIN CALCIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-02-06
END MARKETING DATE: 0000-00-00


Levoleucovorin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevoleucovorin from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2017-02-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-4130_e681ee9e-e794-45e9-8033-5fc913efbb2a
PRODUCT NDC: 0591-4130
APPLICATION NUMBER: NDA208723

Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.levoleucovorin
Amneal BiosciencesLevoleucovorin
Mylan Institutional LLCLEVOLEUCOVORIN CALCIUM
Spectrum Pharmaceuticals, Inc.Fusilev
West-Ward Pharmaceuticals CorpLevoleucovorin